Compare CYD & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYD | ALMR |
|---|---|---|
| Founded | 1951 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1998 | 2026 |
| Metric | CYD | ALMR |
|---|---|---|
| Price | $39.88 | $34.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | 101.1K | ★ 299.0K |
| Earning Date | 02-24-2026 | N/A |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.11 | N/A |
| Revenue Next Year | $8.67 | N/A |
| P/E Ratio | $32.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.65 | $21.58 |
| 52 Week High | $61.48 | $38.54 |
| Indicator | CYD | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 33.14 | 65.56 |
| Support Level | $35.21 | $32.00 |
| Resistance Level | $45.94 | $38.54 |
| Average True Range (ATR) | 2.29 | 2.81 |
| MACD | -0.78 | 0.44 |
| Stochastic Oscillator | 17.61 | 68.10 |
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.